Practically every brand you could think of was in attendance one way or another, and our eager Windows Central colleagues ...

CNBC's Jim Cramer breaks down why he's keeping an eye on shares of AMD.

An event aimed at raising awareness of the most common cause of sight loss in the UK will return to Doncaster next month.

Character Biosciences, a pioneer in genetics-guided drug discovery and development, today announced a collaboration with Bausch + Lomb, a leading global eye health company, to develop innovative ...

Alienware unveiled a new 27-inch 4K QD-OLED gaming monitor at CES 2025, it's designed for gamers who want more PPI across 27 ...

Alienware unveiled a new 27-inch 4K QD-OLED gaming monitor at CES 2025, it's designed for gamers who want more PPI across 27 ...

Soliddd, an optical and vision technology company, will debut the beta headset version of its virtual reality smart glasses ...

Asus breathes new life into its Zenbook lineup with an affordable A14 packing Qualcomm's Snapdragon X processors, a ...

Catch up on the clinical trial news, updates from the United States Food and Drug Administration (FDA), and company funding ...

The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55.

AMD chips abound in gaming laptops this year at CES. I chatted with AMD's Chief Architect of Gaming Solutions about the ...

Dell has overhauled its PC product lineup by shunting nearly all of its PC models into three tracks: Dell, Dell Pro, and Dell ...